article thumbnail

Too Much of a Good Thing? Unpacking the Rise of Polypharmacy in Seniors

PharmD Live

These guidelines are often based on the best available evidence for treating individual diseases but may not fully consider the implications of multimorbidity (American Geriatrics Society, 2019). “Medication Management in Long-Term Care,” Clinical Interventions in Aging , 2019). Reference: Jones, R.

article thumbnail

COVID-19 and the digital pharma marketing revolution

pharmaphorum

Healthcare companies have been in the vanguard of this change, with an enormous rise in the use of telehealth and all forms of digital communications. compared with 2019, and the digital spend is forecast to increase to $11.25 The global outbreak of COVID-19 has forced businesses to radically change their way of working.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Why R&D innovation holds the key to greater patient impact

European Pharmaceutical Review

In 2019, the pharmaceutical industry spent $83 billion on R&D, which is about 10 times what the industry spent per year in the 1980s, 4 yet the average duration to develop a new medicine is still around 10-15 years. About the authors Dr Nils Eckardt joined BeiGene in February 2019 as Vice President, Medical Affairs, Europe.

article thumbnail

Amlodipine interactions to avoid

The Checkup by Singlecare

Amlodipine can compound those problems. Communicate these lists to every healthcare provider that cares for you. You must be vigilant in keeping up-to-date lists of your prescription drugs, over-the-counter therapies, supplements, and health conditions. It also pays to be open-minded to other options for hypertension management.

article thumbnail

Is Chantix Safe Again After the Nationwide Recall?

BuzzRx

The recalled drugs (Chantix tablets) were distributed nationwide in the US and its territories between May 2019 and September 2021. mg and 1 mg tablets were recalled due to the presence of a nitrosamine compound called N-nitroso-varenicline at or above the Food and Drug Administration (FDA’s) acceptable intake limit. Chantix 0.5

article thumbnail

2022 spells change for EU pharmaceutical legislation

European Pharmaceutical Review

The review was impacted by Brexit and the COVID-19 pandemic, which compounded existing issues surrounding high drug pricing and patient access that had been brewing since 2016 and highlighted several shortcomings in the EU’s pharmaceutical system. Amsterdam: Gupta Strategists; 2019. About the author. References. European Commission.

article thumbnail

Three strategies for managing loss of exclusivity successfully

pharmaphorum

Eli Lilly’s Humalog compound and formulation patents expired in 2013 and 2014, respectively. However, 2019 saw Eli Lilly respond to criticism of high insulin prices by launching a cut-price version. Between December 1, 2018 and January 31, 2019, 65% of erectile dysfunction prescriptions filled were for Viagra or its generic version 12.